Cbg Pathway

The CBG pathway refers to cannabis plants exhibiting elevated cannabigerol (CBG) production, a non-intoxicating cannabinoid that serves as a biosynthetic precursor to CBD, THC, and CBC in the plant. CBG-dominant strains typically result from selective breeding for specific genetic variants that favor early-stage cannabinoid production before further enzymatic conversion occurs. Lineage records frequently report that CBG-enriched phenotypes emerge from crosses emphasizing cannabis sativa genetics and strains with known cannabinoid pathway variations. These plants are of particular interest to breeders studying cannabinoid chemistry and the molecular basis of strain diversity. CBG content varies significantly based on harvest timing, growing conditions, and underlying genotype, making this trait a focus for controlled cultivation research.

Breeders working with CBG-pathway genetics study how specific genotypes regulate cannabinoid synthase enzyme expression and timing. This research informs broader cannabinoid breeding programs and contributes to understanding plant biochemistry across the cannabis family.